Process for inhibiting herpes simplex virus-specified thymidine

Details Process for inhibiting herpes simplex virus-specified thymidine Process for inhibiting herpes simplex virus-specified thymidine

1987-03-20

1991-04-16

Rollins, John W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514729, 514934, A61K 3170, A61K 31045

Patent

active

050082523

ABSTRACT:
The invention relates to a method of selectively inhibiting herpes simplex virus-specified thymidine kinase. The method comprises exposing mammalian cells infected with the virus to an effective amount of 5'-ethynylthymidine. The invention further relates to a pharmaceutical composition comprising 5'-ethynylthymidine as the active ingredient together with a pharmaceutically acceptable carrier.

REFERENCES:
Sharma et al., J. Org. Chem. 43, No. 2, pp. 367-369 (1978).
Nutter et al., the Chemical Abstracts 106:188509g (1987).

Affiliated with

Also associated with

Rating

Process for inhibiting herpes simplex virus-specified thymidine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for inhibiting herpes simplex virus-specified thymidine , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for inhibiting herpes simplex virus-specified thymidine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-421317